With U.S. Blood Donations at a 20-Year Low, New Research Published in the Journal Blood Demonstrates How the Additive Could Extend Platelet Storage to 14 Days, Significantly Reducing Contamination Risk and Waste CINCINNATI , Aug.
21, 2024 /PRNewswire/ -- Preservation Bio, a leader in platelet preservation technology, today announced a major advancement in transfusion medicine, validated by a pivotal study published in the prestigious journal Blood . The research, led by Preservation Bio's scientific co-founders, Dr. Jose Cancelas and Dr.
Yi Zheng , introduces an innovative ex vivo platelet additive that could revolutionize blood banking by enabling long-term cold storage of platelets. The United States is facing a severe crisis in the blood supply chain, with the American Red Cross reporting the lowest number of blood donors in 20 years. This blood shortage has significant implications, particularly for platelet supplies, which are essential for many life-saving medical procedures.
Preservation Bio's innovative ex vivo platelet additive addresses this critical blood supply challenge by enabling the long-term cold storage of platelets for up to 14 days. This breakthrough in refrigeration offers several key advantages, including the potential to extend platelet shelf life well beyond the current 5-7 days, thereby reducing seasonal and regional fluctuations in platelet supply and minimizing waste. "Our innovation represents a promising advancement in platelet storage that could .